Shared signatures between rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome uncovered through gene expression meta-analysis

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Toro Domínguez, Daniel ^a   Carmona Sáez, Pedro ^a   Alarcón Riquelme, Marta E ^a,b  

^a UNIVERSITY OF GRANADA   (Spain)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; TRANSCRIPTOME;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HERC6 GENE; HUMAN; IFI44L GENE; IFIT1 GENE; IFIT1M1 GENE; IFIT27 GENE; IMMUNE RESPONSE; INFLAMMATION; MAJOR CLINICAL STUDY; META ANALYSIS; MITOSIS; PROTEIN SYNTHESIS; RHEUMATOID ARTHRITIS; RSAD2 GENE; RTP4 GENE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; ARTHRITIS, RHEUMATOID; GENE EXPRESSION PROFILING; GENETIC DATABASE; GENETICS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROCEDURES; SJOGREN'S SYNDROME;

ARTHRITIS, RHEUMATOID; DATABASES, GENETIC; GENE EXPRESSION PROFILING; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SJOGREN'S SYNDROME; TRANSCRIPTOME;

EID: 84924289482     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-014-0489-x     Document Type: Article

References (49)

1. Karopka T, Fluck J, Mevissen HT, Glass Ä: The Autoimmune Disease Database: a dynamically compiled literature-derived database. BMC Bioinformatics 2006, 7:325.
2. Salaman MR: A two-step hypothesis for the appearance of autoimmune disease. Autoimmunity 2003, 36:57-61.
3. Burska AN, Roget K, Blits M, Soto Gomez L, van de Loo F, Hazelwood LD, Verweij CL, Rowe A, Goulielmos GN, van Baarsen LGM, Ponchel F: Gene expression analysis in RA: towards personalized medicine. Pharmacogenomics J 2014, 14:93-106.
4. Tuller T, Atar S, Ruppin E, Gurevich M, Achiron A: Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases. Genes Immun 2013, 14:67-82.
5. van 't Veer LJ, Bernards R: Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 2008, 452:564-570.
6. Song GG, Kim JH, Seo YH, Choi SJ, Ji JD, Lee YH: Meta-analysis of differentially expressed genes in primary Sjogren's syndrome by using microarray. Hum Immunol 2014, 75:98-104.
7. Arasappan D, Tong W, Mummaneni P, Fang H, Amur S: Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells. BMC Med 2011, 9:65.
8. Olsen N, Sokka T, Seehorn CL, Kraft B, Maas K, Moore J, Aune TM: A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. Ann Rheum Dis 2004, 63:1387-1392.
9. Olsen NJ, Moore JH, Aune TM: Gene expression signatures for autoimmune disease in peripheral blood mononuclear cells. Arthritis Res Ther 2004, 6:120-128.
10. Silva GL, Junta CM, Mello SS, Garcia PS, Rassi DM, Sakamoto-Hojo ET, Donadi EA, Passos GAS: Profiling meta-analysis reveals primarily gene coexpression concordance between systemic lupus erythematosus and rheumatoid arthritis. Ann N Y Acad Sci 2007, 1110:33-46.
11. Higgs BW, Liu Z, White B, Zhu W, White WI, Morehouse C, Brohawn P, Kiener PA, Richman L, Fiorentino D, Greenberg SA, Jallal B, Yao Y: Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway. Ann Rheum Dis 2011, 70:2029-2036.
12. Higgs BW, Zhu W, Richman L, Fiorentino DF, Greenberg SA, Jallal B, Yao Y: Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients. Int J Rheum Dis 2012, 15:25-35.
13. National Center for Biotechnology Information: Gene Expression Omnibus. [ http://www.ncbi.nlm.nih.gov/geo/ ] (accessed 17 December 2014).
14. Davis S, Meltzer PS: GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 2007, 23:1846-1847.
15. Xia J, Fjell CD, Mayer ML, Pena OM, Wishart DS, Hancock REW: INMEX-a web-based tool for integrative meta-analysis of expression data. Nucleic Acids Res 2013, 41(Web server issue):W63-W70.
16. Choi JK, Yu U, Kim S, Yoo OJ: Combining multiple microarray studies and modeling interstudy variation. Bioinformatics 2003, 19:i84-i90.
17. Marot G, Foulley JL, Mayer CD, Jaffrézic F: Moderated effect size and P -value combinations for microarray meta-analyses. Bioinformatics 2009, 25:2692-2699.
18. GeneCodis: [ http://genecodis.cnb.csic.es/ ] (accessed 17 December 2014).
19. Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A: GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol 2007, 8:R3.
20. Nogales-Cadenas R, Carmona-Saez P, Vazquez M, Vicente C, Yang X, Tirado F, Carazo JM, Pascual-Montano A: GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res 2009, 37(Web server issue):W317-W322.
21. Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A: GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res 2012, 40(Webserver issue):W478-W483.
22. Hutcheson J, Scatizzi JC, Siddiqui AM, Haines GK 3rd, Wu T, Li QZ, Davis LS, Mohan C, Perlman H: Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity. Immunity 2008, 28:206-217.
23. Teixeira VH, Olaso R, Martin-Magniette ML, Lasbleiz S, Jacq L, Oliveira CR, Hilliquin P, Gut I, Cornelis F, Petit-Teixeira E: Transcriptome analysis describing new immunity and defense genes in peripheral blood mononuclear cells of rheumatoid arthritis patients. PLoS One 2009, 4:e6803.
24. Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, Kelly JA, Dozmorov MG, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, Brun JG, Gøransson LG, Harboe E, Guthridge JM, Kaufman KM, Kvarnström M, Jazebi H, Graham DSC, Grandits ME, Nazmul-Hossain ANM, Patel K, Adler AJ, Maier-Moore JS, Farris AD, Brennan MT, Lessard JA, Chodosh J, et al: Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet 2013, 45:1284-1292.
25. Yao Y, Higgs BW, Morehouse C, de los Reyes M, Trigona W, Brohawn P, White W, Zhang J, White B, Coyle AJ, Kiener PA, Jallal B: Development of potential pharmacodynamic and diagnostic markers for anti-IFN-α monoclonal antibody trials in systemic lupus erythematosus. Hum Genomics Proteomics 2009, 1:374312.
26. Sun HG, Dong XJ, Lu T, Yang MF, Wang XM: Clinical value of eukaryotic elongation factor 2 (eEF2) in non-small cell lung cancer patients. Asian Pac J Cancer Prev 2014, 14:6533-6535.
27. Tseng GC, Ghosh D, Feingold E: Comprehensive literature review and statistical considerations for microarray meta-analysis. Nucleic Acids Res 2012, 40:3785-3799.
28. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, Behrens TW: Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003, 100:2610-2615.
29. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003, 197:711-723.
30. Bezalel S, Guri KM, Elbirt D, Asher I, Sthoeger ZM: Type I interferon signature in systemic lupus erythematosus. Isr Med Assoc J 2014, 16:246-249.
31. Salloum R, Niewold TB: Interferon regulatory factors in human lupus pathogenesis. Transl Res 2011, 157:326-331.
32. Grolleau A, Kaplan MJ, Hanash SM, Beretta L, Richardson B: Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients. J Clin Invest 2000, 106:1561-1568.
33. Brkic Z, Versnel MA: Type I IFN signature in primary Sjögren's syndrome patients. Expert Rev Clin Immunol 2014, 10:457-467.
34. Le Page C, Génin P, Baines MG, Hiscott J: Interferon activation and innate immunity. Rev Immunogenet 2000, 2:374-386.
35. Malemud CJ: Intracellular signaling pathways in rheumatoid arthritis. J Clin Cell Immunol 2013, 4:160.
36. Zhu J, Zhang Y, Ghosh A, Cuevas RA, Forero A, Dhar J, Ibsen MS, Schmid-Burgk JL, Schmidt T, Ganapathiraju MK, Fujita T, Hartmann R, Barik S, Hornung V, Coyne CB, Sarkar SN: Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor. Immunity 2014, 40:936-948.
37. Lu MM, Ye QL, Feng CC, Yang J, Zhang T, Li J, Leng RX, Pan HF, Yuan H, Ye DQ: Association of FAS gene polymorphisms with systemic lupus erythematosus: a case-control study and meta-analysis. Exp Ther Med 2012, 4:497-502.
38. Treviño-Talavera BA, Palafox-Sánchez CA, Muñoz-Valle JF, Orozco-Barocio G, Navarro-Hernández RE, Vázquez-Del Mercado M, García de la Torre I, Oregon-Romero E: FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome. Genet Mol Res 2014, 13:4831-4838.
39. Colonna L, Lood C, Elkon KB: Beyond apoptosis in lupus. Curr Opin Rheumatol 2014, 26:459-466.
40. Biermann MH, Veissi S, Maueröder C, Chaurio R, Berens C, Herrmann M, Munoz LE: The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets. Expert Rev Clin Immunol 2014, 10:1151-1164.
41. Zhang S, Sun Y, Chen H, Dai Y, Zhan Y, Yu S, Qiu X, Tan L, Song C, Ding C: Activation of the PKR/eIF2α signaling cascade inhibits replication of Newcastle disease virus. Virol J 2014, 11:62.
42. Bullido MJ, Martínez-García A, Tenorio R, Sastre I, Muñoz DG, Frank A, Valdivieso F: Double stranded RNA activated EIF2α kinase ( EIF2AK2. PKR ) is associated with Alzheimer's disease. Neurobiol Aging 2008, 29:1160-1166.
43. Sadler AJ, Williams BRG: Structure and function of the protein kinase R. Curr Top Microbiol Immunol 2007, 316:253-292.
44. Gilbert SJ, Duance VC, Mason DJ: Does protein kinase R mediate TNF-α- and ceramide-induced increases in expression and activation of matrix metalloproteinases in articular cartilage by a novel mechanism? Arthritis Res Ther 2003, 6:R46.
45. Gilbert SJ, Duance VC, Mason DJ: Protein kinase R: a novel mediator of articular cartilage degradation in arthritis. Curr Rheumatol Rev 2006, 2:9-21.
46. Yeung MC, Liu J, Lau AS: An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc Natl Acad Sci U S A 1996, 93:12451-12455.
47. Ward SV, Samuel CE: The PKR kinase promoter binds both Sp1 and Sp3, but only Sp3 functions as part of the interferon-inducible complex with ISGF-3 proteins. Virology 2003, 313:553-566.
48. McAllister CS, Taghavi N, Samuel CE: Protein kinase PKR amplification of interferon β induction occurs through initiation factor eIF-2α-mediated translational control. J Biol Chem 2012, 287:36384-36392.
49. Kumar H, Kawai T, Akira S: Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009, 388:621-625.